The role of dendritic cells in tissue-specific autoimmunity

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Mbongue, Jacques ^a   Nicholas, Dequina ^a   Firek, Anthony ^b   Langridge, William ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE; RAPAMYCIN; IMMUNOLOGIC FACTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CELL THERAPY; CLINICAL ASSESSMENT; DENDRITIC CELL; ENCEPHALOMYELITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LANGERHANS CELL; PLASMACYTOID DENDRITIC CELL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE SPECIFICITY; ADAPTIVE IMMUNITY; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASES; BIOLOGICAL THERAPY; CELL LINEAGE; CLASSIFICATION; CYTOLOGY; GENE THERAPY; IMMUNOLOGY; INNATE IMMUNITY; PATHOLOGY;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL LINEAGE; CELL- AND TISSUE-BASED THERAPY; DENDRITIC CELLS; GENETIC THERAPY; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; ORGAN SPECIFICITY;

EID: 84901036228     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/857143     Document Type: Review

References (162)

1. Steinman R. M., Cohn Z. A., Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. The Journal of Experimental Medicine 2007 137 5 1142 1162
2. Steinman R. M., Cohn Z. A., Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. The Journal of Experimental Medicine 1974 139 2 380 397 2-s2.0-0015949926
3. Moberg C. L., An appreciation of Ralph Marvin Steinman (1943-2011). The Journal of Experimental Medicine 2011 208 12 2337 2342 2-s2.0-84855748535 10.1084/jem.20112294
4. Steinman R. M., Witmer M. D., Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proceedings of the National Academy of Sciences of the United States of America 1978 75 10 5132 5136 2-s2.0-0000810758 (Pubitemid 9046495)
5. Nussenzweig M. C., Steinman R. M., Gutchinov B., Cohn Z. A., Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. The Journal of Experimental Medicine 1980 152 4 1070 1084 2-s2.0-0018966159 (Pubitemid 10010887)
6. Van Voorhis W. C., Hair L. S., Steinman R. M., Kaplan G., Human dendritic cells. Enrichment and characterization from peripheral blood. The Journal of Experimental Medicine 1982 155 4 1172 1187 2-s2.0-0020031143 (Pubitemid 12142732)
7. Caux C., Dezutter-Dambuyant C., Schmit D., Banchereau J., GM-CSF and TNF- α cooperate in the generation of dendritic Langerhans cells. Nature 1992 360 6401 258 261 2-s2.0-0026446156 10.1038/360258a0
8. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinman R. M., Schuler G., Proliferating dendritic cell progenitors in human blood. The Journal of Experimental Medicine 1994 180 1 83 93 2-s2.0-0028285230 10.1084/jem.180.1.83 (Pubitemid 24181058)
9. van Spriel A. B., de Jong E. C., Dendritic cell science: more than 40 years of history. Journal of Leukocyte Biology 2013 93 1 33 38
10. Katsnelson A., Kicking off adaptive immunity: the discovery of dendritic cells. The Journal of Experimental Medicine 2006 203 7 1622 2-s2.0-33745811676 10.1084/jem.2037fta (Pubitemid 44036264)
11. Rowley D. A., Fitch F. W., The road to the discovery of dendritic cells, a tribute to Ralph Steinman. Cellular Immunology 2012 273 2 95 98 2-s2.0-84857190237 10.1016/j.cellimm.2012.01.002
12. De Trez C., Magez S., Akira S., Ryffel B., Carlier Y., Muraille E., iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathogens 2009 5 6 2-s2.0-67650869758 10.1371/journal.ppat.1000494 e1000494
13. Serbina N. V., Salazar-Mather T. P., Biron C. A., Kuziel W. A., Pamer E. G., TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003 19 1 59 70 2-s2.0-0037625155 10.1016/S1074-7613(03)00171-7 (Pubitemid 36859901)
14. Luo G., Niesel D. W., Shaban R. A., Grimm E. A., Klimpel G. R., Tumor necrosis factor alpha binding to bacteria: Evidence for a high- affinity receptor and alteration of bacterial virulence properties. Infection and Immunity 1993 61 3 830 835 2-s2.0-0027411540 (Pubitemid 23059637)
15. Barreira Da Silva R., Münz C., Natural killer cell activation by dendritic cells: Balancing inhibitory and activating signals. Cellular and Molecular Life Sciences 2011 68 21 3505 3518 2-s2.0-80054746187 10.1007/s00018-011-0801-8
16. Hubert F.-X., Kinkel S. A., Davey G. M., Phipson B., Mueller S. N., Liston A., Proietto A. I., Cannon P. Z. F., Forehan S., Smyth G. K., Wu L., Goodnow C. C., Carbone F. R., Scott H. S., Heath W. R., Aire regulates the transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance. Blood 2011 118 9 2462 2472 2-s2.0-80052423824 10.1182/blood-2010-06- 286393
17. Gallegos A. M., Bevan M. J., Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. The Journal of Experimental Medicine 2004 200 8 1039 1049 2-s2.0-7244227645 10.1084/jem.20041457 (Pubitemid 39431128)
18. Proietto A. I., Van Dommelen S., Zhou P., Rizzitelli A., D'Amico A., Steptoe R. J., Naik S. H., Lahoud M. H., Liu Y., Zheng P., Shortman K., Wu L., Dendritic cells in the thymus contribute to T-regulatory cell induction. Proceedings of the National Academy of Sciences of the United States of America 2008 105 50 19869 19874 2-s2.0-58149376454 10.1073/pnas.0810268105
19. Bonasio R., Scimone M. L., Schaerli P., Grabie N., Lichtman A. H., von Andrian U. H., Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nature Immunology 2006 7 10 1092 1100 2-s2.0-33748866909 10.1038/ni1385 (Pubitemid 44420654)
20. Probst H. C., McCoy K., Okazaki T., Honjo T., Van Den Broek M., Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nature Immunology 2005 6 3 280 286 2-s2.0-14944360112 10.1038/ni1165 (Pubitemid 41724765)
21. Ganguly D., Haak S., Sisirak V., Reizis B., The role of dendritic cells in autoimmunity. Nature Reviews Immunology 2013 13 8 566 577
22. Teichmann L. L., Ols M. L., Kashgarian M., Reizis B., Kaplan D. H., Shlomchik M. J., Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 2010 33 6 967 978 2-s2.0-78650108453 10.1016/j.immuni.2010.11.025
23. Lewis K. L., Reizis B., Dendritic cells: arbiters of immunity and immunological tolerance. Cold Spring Harbor Perspectives in Biology 2012 4 8 a007401 10.1101/cshperspect.a007401
24. Belz G. T., Nutt S. L., Transcriptional programming of the dendritic cell network. Nature Reviews Immunology 2012 12 2 101 113 2-s2.0-84856159067 10.1038/nri3149
25. Brasel K., De Smedt T., Smith J. L., Maliszewski C. R., Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000 96 9 3029 3039 2-s2.0-0034332450
26. Cheong C., Matos I., Choi J.-H., Dandamudi D. B., Shrestha E., Longhi M. P., Jeffrey K. L., Anthony R. M., Kluger C., Nchinda G., Koh H., Rodriguez A., Idoyaga J., Pack M., Velinzon K., Park C. G., Steinman R. M., Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209+ dendritic cells for immune T cell areas. Cell 2010 143 3 416 429 2-s2.0-77958500026 10.1016/j.cell.2010.09.039
27. Chorro L., Sarde A., Li M., Woollard K. J., Chambon P., Malissen B., Kissenpfennig A., Barbaroux J.-B., Groves R., Geissmann F., Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. The Journal of Experimental Medicine 2009 206 13 3089 3100 2-s2.0-73949147392 10.1084/jem.20091586
28. Petvises S., O'Neill H. C., Hematopoiesis leading to a diversity of dendritic antigen-presenting cell types. Immunology and Cell Biology 2012 90 4 372 378 2-s2.0-84859947724 10.1038/icb.2011.47
29. Liu K., Nussenzweig M. C., Origin and development of dendritic cells. Immunological Reviews 2010 234 1 45 54 2-s2.0-77349124883 10.1111/j.0105-2896. 2009.00879.x
30. Naik S. H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K., Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nature Immunology 2006 7 6 663 671 2-s2.0-33744473294 10.1038/ni1340 (Pubitemid 43797348)
31. Shortman K., Naik S. H., Steady-state and inflammatory dendritic-cell development. Nature Reviews Immunology 2007 7 1 19 30 2-s2.0-33845898737 10.1038/nri1996 (Pubitemid 46020824)
32. León B., López-Bravo M., Ardavín C., Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007 26 4 519 531 2-s2.0-34247104151 10.1016/j.immuni.2007.01.017 (Pubitemid 46602998)
33. Reizis B., Bunin A., Ghosh H. S., Lewis K. L., Sisirak V., Plasmacytoid dendritic cells: recent progress and open questions. Annual Review of Immunology 2011 29 163 183 2-s2.0-79953059788 10.1146/annurev-immunol-031210-101345
34. Trinchieri G., Santoli D., Dee R. R., Knowles B. B., Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. The Journal of Experimental Medicine 1978 147 5 1299 1313 2-s2.0-0018089641 (Pubitemid 8328673)
35. Hubert F.-X., Voisine C., Louvet C., Heslan M., Josien R., Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of toll-like receptors 7 and 9 and strong responsiveness to CpG. The Journal of Immunology 2004 172 12 7485 7494 2-s2.0-2942530614 (Pubitemid 38747611)
36. Reizis B., Colonna M., Trinchieri G., Barrat F., Gilliet M., Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nature Reviews Immunology 2011 11 8 558 565 2-s2.0-79960835493 10.1038/nri3027
37. Kamath A. T., Henri S., Battye F., Tough D. F., Shortman K., Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002 100 5 1734 1741 2-s2.0-0036721329 (Pubitemid 34925152)
38. Tezuka H., Abe Y., Iwata M., Takeuchi H., Ishikawa H., Matsushita M., Shiohara T., Akira S., Ohteki T., Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 2007 448 7156 929 933 2-s2.0-34548176272 10.1038/nature06033 (Pubitemid 47312771)
39. Nakano H., Lin K. L., Yanagita M., Charbonneau C., Cook D. N., Kakiuchi T., Gunn M. D., Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nature Immunology 2009 10 4 394 402 2-s2.0-62849119018 10.1038/ni.1707
40. Segura E., Albiston A. L., Wicks I. P., Chai S. Y., Villadangos J. A., Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2009 106 48 20377 20381 2-s2.0-73949097613 10.1073/pnas.0910295106
41. Zhu J., Yamane H., Paul W. E., Differentiation of effector CD4+ T cell populations. Annual Review of Immunology 2010 28 445 489 2-s2.0-77952313777 10.1146/annurev-immunol-030409-101212
42. Yamane H., Paul W. E., Early signaling events that underlie fate decisions of naive CD4+ T cells toward distinct T-helper cell subsets. Immunological Reviews 2013 252 1 12 23 10.1111/imr.12032
43. Tang D., Kang R., Coyne C. B., Zeh H. J., Lotze M. T., PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunological Reviews 2013 249 1 158 175 10.1111/j.1600-065X.2012.01146.x
44. Probst H. C., Lagnel J., Kollias G., van den Broek M., Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 2003 18 5 713 720 2-s2.0-0038325761 10.1016/S1074-7613(03) 00120-1 (Pubitemid 36588587)
45. Kyewski B., Klein L., A central role for central tolerance. Annual Review of Immunology 2006 24 571 606 2-s2.0-33646165128 10.1146/annurev.immunol.23. 021704.115601
46. Mayer C. T., Berod L., Sparwasser T., Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Frontiers in Immunology 2012 3, article 183
47. Maldonado R. A., von Andrian U. H., How tolerogenic dendritic cells induce regulatory T cells. Advances in Immunology 2010 108 111 165 2-s2.0-78149277909 10.1016/B978-0-12-380995-7.00004-5
48. Pallotta M. T., Orabona C., Volpi C., Vacca C., Belladonna M. L., Bianchi R., Servillo G., Brunacci C., Calvitti M., Bicciato S., Mazza E. M. C., Boon L., Grassi F., Fioretti M. C., Fallarino F., Puccetti P., Grohmann U., Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nature Immunology 2011 12 9 870 878 2-s2.0-80052020183 10.1038/ni.2077
49. Rothlin C. V., Ghosh S., Zuniga E. I., Oldstone M. B. A., Lemke G., TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007 131 6 1124 1136 2-s2.0-36849033963 10.1016/j.cell.2007.10.034 (Pubitemid 350235020)
50. Kushwah R., Oliver J. R., Zhang J., Siminovitch K. A., Hu J., Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. The Journal of Immunology 2009 183 11 7104 7118 2-s2.0-73349089343 10.4049/jimmunol.0900824
51. Kushwah R., Wu J., Oliver J. R., Jiang G., Zhang J., Siminovitch K. A., Hu J., Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. European Journal of Immunology 2010 40 4 1022 1035 2-s2.0-77951033594 10.1002/eji.200939782
52. Geijtenbeek T. B. H., van Vliet S. J., Engering A., 'T Hart B. A., van Kooyk Y., Self- and nonself-recognition by C-type lectins on dendritic cells. Annual Review of Immunology 2004 22 33 54 2-s2.0-2542474306 10.1146/annurev. immunol.22.012703.104558 (Pubitemid 38680417)
53. Hopp A. K., Rupp A., Lukacs-Kornek V., Self-antigen presentation by dendritic cells in autoimmunity. Frontiers in Immunology 2014 5, article 55 10.3389/fimmu.2014.00055
54. Morel P. A., Dendritic cell subsets in type 1 diabetes: friend or foe? Frontiers in Immunology 2013 4, article 415 10.3389/fimmu.2013.00415
55. Steptoe R. J., Ritchie J. M., Harrison L. C., Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. The Journal of Immunology 2002 168 10 5032 5041 2-s2.0-0037093840 (Pubitemid 34495966)
56. Saxena V., Ondr J. K., Magnusen A. F., Munn D. H., Katz J. D., The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. The Journal of Immunology 2007 179 8 5041 5053 2-s2.0-38449111402
57. Swiecki M., Mccartney S. A., Wang Y., Colonna M., TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes. Journal of Leukocyte Biology 2011 90 4 691 701 2-s2.0-80053365133 10.1189/jlb.0311166
58. Båve U., Nordmark G., Lövgren T., Rönnelid J., Cajander S., Eloranta M.-L., Alm G. V., Rönnblom L., Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis and Rheumatism 2005 52 4 1185 1195 2-s2.0-17244372491 10.1002/art.20998 (Pubitemid 40530126)
59. Wahren-Herlenius M., Dorner T., Immunopathogenic mechanisms of systemic autoimmune disease. The Lancet 2013 382 9894 819 831
60. Elkon K. B., Stone V. V., Type I interferon and systemic lupus erythematosus. Journal of Interferon and Cytokine Research 2011 31 11 803 812 2-s2.0-80955139536 10.1089/jir.2011.0045
61. Roep B. O., Peakman M., Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harbor Perspectives in Medicine 2012 2 4 a007781 10.1101/cshperspect.a007781
62. Bottazzo G. F., Florin Christensen A., Doniach D., Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. The Lancet 1974 2 7892 1279 1283 2-s2.0-0016261369
63. Baekkeskov S., Aanstoot H.-J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., Camilli P.-D., Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutatmic acid decarboxylase. Nature 1990 347 6289 151 156 2-s2.0-0025039679 10.1038/347151a0 (Pubitemid 20315873)
64. Lutterotti A., Yousef S., Sputtek A., Stürner K. H., Stellmann J. P., Breiden P., Reinhardt S., Schulze C., Bester M., Heesen C., Schippling S., Miller S. D., Sospedra M., Martin R., Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Science Translational Medicine 2013 5 188 188ra75 10.1126/scitranslmed.3006168
65. de Rosbo N. K., Milo R., Lees M. B., Burger D., Bernard C. C. A., Ben-Nun A., Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. Journal of Clinical Investigation 1993 92 6 2602 2608 2-s2.0-0027144752 (Pubitemid 24006523)
66. Lamagna C., Scapini P., van Ziffle J. A., DeFranco A. L., Lowell C. A., Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proceedings of the National Academy of Sciences of the United States of America 2013 110 35 E3311 E3320 10.1073/pnas.1300617110
67. Cohen P. L., Caricchio R., Abraham V., Camenisch T. D., Charles Jennette J., Roubey R. A. S., Shelton Earp H., Matsushima G., Reap E. A., Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. The Journal of Experimental Medicine 2002 196 1 135 140 2-s2.0-0036645294 10.1084/jem.20012094 (Pubitemid 34747319)
68. Bouts Y. M., Wolthuis D. F., Dirkx M. F., Pieterse E., Simons E. M., van Boekel A. M., Dieker J. W., van der Vlag J., Apoptosis and NET formation in the pathogenesis of SLE. Autoimmunity 2012 45 8 597 601 10.3109/08916934.2012.719953
69. Seitz H. M., Matsushima G. K., Dendritic cells in systemic lupus erythematosus. International Reviews of Immunology 2010 29 2 184 209 2-s2.0-77952510795 10.3109/08830181003602507
70. Holers V. M., Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis. Current Opinion in Immunology 2013 25 6 728 735 10.1016/j.coi.2013.09.018
71. Beltrami A., Rossmann M., Fiorillo M. T., Paladini F., Sorrentino R., Saenger W., Kumar P., Ziegler A., Uchanska-Ziegler B., Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes. Journal of Biological Chemistry 2008 283 40 27189 27199 2-s2.0-55249117017 10.1074/jbc.M802818200
72. Tsark E. C., Wang W., Teng Y.-C., Arkfeld D., Dodge G. R., Kovats S., Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages. The Journal of Immunology 2002 169 11 6625 6633 2-s2.0-0036883904 (Pubitemid 36903517)
73. Marin-Gallen S., Clemente-Casares X., Planas R., Pujol-Autonell I., Carrascal J., Carrillo J., Ampudia R., Verdaguer J., Pujol-Borrell R., Borràs F. E., Vives-Pi M., Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. Clinical and Experimental Immunology 2010 160 2 207 214 2-s2.0-77950637110 10.1111/j.1365-2249.2009. 04082.x
74. Leiter E. H., Prochazka M., Coleman D. L., The non-obese diabetic (NOD) mouse. The American Journal of Pathology 1987 128 2 380 383 2-s2.0-0023216950 (Pubitemid 17122347)
75. Welzen-Coppens J. M. C., van Helden-Meeuwsen C. G., Leenen P. J. M., Drexhage H. A., Versnel M. A., The kinetics of plasmacytoid dendritic cell accumulation in the pancreas of the NOD mouse during the early phases of insulitis. PLoS ONE 2013 8 1 e55071 10.1371/journal.pone.0055071
76. Saxena V., Ondr J. K., Magnusen A. F., Munn D. H., Katz J. D., The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. The Journal of Immunology 2007 179 8 5041 5053 2-s2.0-38449111402
77. Vieira P., De Waal-Malefyt R., Dang M.-N., Johnson K. E., Kastelein R., Fiorentino D. F., DeVries J. E., Roncarolo M.-G., Mosmann T. R., Moore K. W., Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proceedings of the National Academy of Sciences of the United States of America 1991 88 4 1172 1176 2-s2.0-0026089934 (Pubitemid 21916187)
78. Mosser D. M., Zhang X., Interleukin-10: new perspectives on an old cytokine. Immunological Reviews 2008 226 1 205 218 2-s2.0-55149094739 10.1111/j.1600-065X.2008.00706.x
79. Suciu-Foca N., Manavalan J. S., Scotto L., Kim-Schulze S., Galluzzo S., Naiyer A. J., Fan J., Vlad G., Cortesini R., Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. International Immunopharmacology 2005 5 1 7 11 2-s2.0-10344249383 10.1016/j.intimp.2004.09. 003 (Pubitemid 39626678)
80. Carosella E. D., Gregori S., LeMaoult J., The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood 2011 118 25 6499 6505 2-s2.0-84055218980 10.1182/blood-2011-07-370742
81. Weaver D.J. J., Poligone B., Bui T., Abdel-Motal U. M., Baldwin A.S. J., Tisch R., Dendritic cells from nonobese diabetic mice exhibit a defect in NF- B regulation due to a hyperactive I B kinase. The Journal of Immunology 2001 167 3 1461 1468 2-s2.0-0035424898 (Pubitemid 32703145)
82. Tisch R., Wang B., Role of plasmacytoid dendritic cells in type 1 diabetes: friend or foe? Diabetes 2009 58 1 12 13 2-s2.0-63249135325 10.2337/db08-1341
83. Steinbrink K., Wölfl M., Jonuleit H., Knop J., Enk A. H., Induction of tolerance by IL-10-treated dendritic cells. The Journal of Immunology 1997 159 10 4772 4780 2-s2.0-0031573204 (Pubitemid 127471012)
84. Martino G., Hartung H.-P., Immunopathogenesis of multiple sclerosis: the role of T cells. Current Opinion in Neurology 1999 12 3 309 321 2-s2.0-0032772860 10.1097/00019052-199906000-00010 (Pubitemid 29378165)
85. Viglietta V., Baecher-Allan C., Weiner H. L., Hafler D. A., Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis. The Journal of Experimental Medicine 2004 199 7 971 979 2-s2.0-1842732224 10.1084/jem.20031579 (Pubitemid 38481088)
86. Bailey-Bucktrout S. L., Caulkins S. C., Goings G., Fischer J. A. A., Dzionek A., Miller S. D., Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. The Journal of Immunology 2008 180 10 6457 6461 2-s2.0-45549095991
87. Derkow K., Bauer J. M., Hecker M., Paap B. K., Thamilarasan M., Koczan D., Schott E., Deuschle K., Bellmann-Strobl J., Paul F., Zettl U. K., Ruprecht K., Lehnardt S., Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-beta includes upregulation of TLR7 in plasmacytoid dendritic cells. PLoS ONE 2013 8 8 e70626 10.1371/journal.pone.0070626
88. McKay F. C., Hoe E., Parnell G., Gatt P., Schibeci S. D., Stewart G. J., Booth D. R., IL7Ralpha expression and upregulation by IFNbeta in dendritic cell subsets is haplotype-dependent. PLoS ONE 2013 8 10 e77508 10.1371/journal.pone. 0077508
89. Amodio G., Gregori S., Dendritic cells a double-edge sword in autoimmune responses. Frontiers in Immunology 2012 3, article 233
90. Pashenkov M., Teleshova N., Kouwenhoven M., Kostulas V., Huang Y.-M., Söderström M., Link H., Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis. Clinical and Experimental Immunology 2002 127 3 519 526 2-s2.0-0036239673 10.1046/j.1365-2249.2002.01779.x (Pubitemid 34437825)
91. Nuyts A. H., Lee W. P., Bashir-Dar R., Berneman Z. N., Cools N., Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies? Multiple Sclerosis 2013 19 8 995 1002 10.1177/1352458512473189
92. Isaksson M., Ardesjö B., Rönnblom L., Kämpe O., Lassmann H., Eloranta M.-L., Lobell A., Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. European Journal of Immunology 2009 39 10 2925 2935 2-s2.0-70350539316 10.1002/eji.200839179
93. Ichikawa H. T., Williams L. P., Segal B. M., Activation of APCs through CD40 or toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. The Journal of Immunology 2002 169 5 2781 2787 2-s2.0-0036721808 (Pubitemid 34921028)
94. Segal B. M., Chang J. T., Shevach E. M., CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. The Journal of Immunology 2000 164 11 5683 5688 2-s2.0-0034043957 (Pubitemid 30389809)
95. Vanderlugt C. L., Begolka W. S., Neville K. L., Katz-Levy Y., Howard L. M., Eagar T. N., Bluestone J. A., Miller S. D., The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunological Reviews 1998 164 63 72 2-s2.0-17344363488 10.1111/j.1600-065X.1998.tb01208.x (Pubitemid 28438396)
96. Nicholas D., Odumosu O., Langridge W. H. R., Autoantigen based vaccines for type 1 diabetes. Discovery medicine 2011 11 59 293 301 2-s2.0-80053304954
97. Al-Sabbagh A., Miller A., Santos L. M. B., Weiner H. L., Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. European Journal of Immunology 1994 24 9 2104 2109 2-s2.0-0028146261
98. Reijonen H., Daniels T. L., Lernmark A., Nepom G. T., GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 2000 49 10 1621 1626 2-s2.0-0033815194
99. McRae B. L., Vanderlugt C. L., Dal Canto M. C., Miller S. D., Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine 1995 182 1 75 85 2-s2.0-0029000750 10.1084/jem.182.1.75
100. Vanderlugt C. L., Neville K. L., Nikcevich K. M., Eagar T. N., Bluestone J. A., Miller S. D., Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. The Journal of Immunology 2000 164 2 670 678 2-s2.0-0034650422 (Pubitemid 30043687)
101. Vanderlugt C. L., Miller S. D., Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nature Reviews Immunology 2002 2 2 85 95 2-s2.0-0036481263 (Pubitemid 37323232)
102. Miller S. D., McMahon E. J., Schreiner B., Bailey S. L., Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Annals of the New York Academy of Sciences 2007 1103 179 191 2-s2.0-34249049841 10.1196/annals.1394.023 (Pubitemid 46791123)
103. McMahon E. J., Bailey S. L., Castenada C. V., Waldner H., Miller S. D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Medicine 2005 11 3 335 339 2-s2.0-16244417773 10.1038/nm1202 (Pubitemid 40460563)
104. Zozulya A. L., Clarkson B. D., Ortler S., Fabry Z., Wiendl H., The role of dendritic cells in CNS autoimmunity. Journal of Molecular Medicine 2010 88 6 535 544 2-s2.0-77954562817 10.1007/s00109-010-0607-4
105. Sokolove J., Bromberg R., Deane K. D., Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 2012 7 5 e35296 10.1371/journal.pone.0035296
106. van Bavel C. C., Dieker J. W., Tamboer W. P., van der Vlag J., Berden J. H., Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes. Molecular Immunology 2010 48 1-3 248 256 2-s2.0-78649504710 10.1016/j.molimm.2010.08.003
107. van Bavel C. C., Dieker J., Muller S., Briand J.-P., Monestier M., Berden J. H., van der Vlag J., Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Molecular Immunology 2009 47 2-3 511 516 2-s2.0-70450222929 10.1016/j.molimm.2009.08.009
108. Filippi C. M., Ehrhardt K., Estes E. A., Larsson P., Oldham J. E., von Herrath M. G., TLR2 signaling improves immunoregulation to prevent type 1 diabetes. European Journal of Immunology 2011 41 5 1399 1409 2-s2.0-79955157031 10.1002/eji.200939841
109. Kim D. H., Lee J. C., Lee M. K., Kim K. W., Lee M. S., Treatment of autoimmune diabetes in NOD mice by toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition. Diabetologia 2012 55 12 3308 3317 10.1007/s00125-012-2723-x
110. Cantrell D. A., Smith K. A., The interleukin-2 T-cell system: a new cell growth model. Science 1984 224 4655 1312 1316 2-s2.0-0021271862 (Pubitemid 14113627)
111. Ciesek S., Ringe B. P., Strassburg C. P., Klempnauer J., Manns M. P., Wedemeyer H., Becker T., Effects of cyclosporine on human dendritic cell subsets. Transplantation Proceedings 2005 37 1 20 24 2-s2.0-16244363073 10.1016/j.transproceed.2004.11.055 (Pubitemid 40459675)
112. Bougneres P.-F., Landais P., Boisson C., Carel J.-C., Frament N., Boitard C., Chaussain J.-L., Bach J.-F., Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes 1990 39 10 1264 1272 2-s2.0-0025049497 (Pubitemid 20327064)
113. Sauma D., Fierro A., Mora J. R., Lennon-Duménil A. M., Bono M. R., Rosemblatt M., Morales J., Cyclosporine preconditions dendritic cells during differentiation and reduces IL-2 and IL-12 production following activation: a potential tolerogenic effect. Transplantation Proceedings 2003 35 7 2515 2517 2-s2.0-0242637341 10.1016/j.transproceed.2003.09.020 (Pubitemid 37378045)
114. Sieber M., Baumgrass R., Novel inhibitors of the calcineurin/NFATc hub-alternatives to CsA and FK506? Cell Communication and Signaling 2009 7, article 25 2-s2.0-72849149270 10.1186/1478-811X-7-25
115. Quesniaux V. F. J., Wehrli S., Steiner C., Joergensen J., Schuurman H.-J., Herrmann P., Schreier M. H., Schuler W., The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo. Blood 1994 84 5 1543 1552 2-s2.0-0028100665 (Pubitemid 24273023)
116. Huang S., Bjornsti M.-A., Houghton P. J., Rapamycins: mechanism of action and cellular resistance. Cancer Biology and Therapy 2003 2 3 222 232 2-s2.0-0346362997 10.4161/cbt.2.3.360
117. Fischer R., Turnquist H. R., Taner T., Thomson A. W., Use of rapamycin in the induction of tolerogenic dendritic cells. Dendritic Cells 2009 188 215 232 Handbook of Experimental Pharmacology 10.1007/978-3-540-71029-5-10
118. Artavanis-Tsakonas S., Rand M. D., Lake R. J., Notch signaling: cell fate control and signal integration in development. Science 1999 284 5415 770 776 2-s2.0-0033617522 10.1126/science.284.5415.770 (Pubitemid 29291335)
119. Oswald F., Täuber B., Dobner T., Bourteele S., Kostezka U., Adler G., Liptay S., Schmid R. M., p300 acts as a transcriptional coactivator for mammalian Notch-1. Molecular and Cellular Biology 2001 21 22 7761 7774 2-s2.0-0034775446 10.1128/MCB.21.22.7761-7774.2001 (Pubitemid 32988785)
120. Billiard F., Lobry C., Darrasse-Jèze G., Waite J., Liu X., Mouquet H., DaNave A., Tait M., Idoyaga J., Leboeuf M., Kyratsous C. A., Burton J., Kalter J., Klinakis A., Zhang W., Thurston G., Merad M., Steinman R. M., Murphy A. J., Yancopoulos G. D., Aifantis I., Skokos D., Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice. The Journal of Experimental Medicine 2012 209 5 1011 1028 10.1084/jem.20111615
121. Radtke F., Fasnacht N., MacDonald H. R., Notch signaling in the immune system. Immunity 2010 32 1 14 27 2-s2.0-74549176827 10.1016/j.immuni.2010.01.004
122. Maillard I., Fang T., Pear W. S., Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annual Review of Immunology 2005 23 945 974 2-s2.0-17644382970 10.1146/annurev.immunol.23.021704.115747 (Pubitemid 40563190)
123. Shutter J. R., Scully S., Fan W., Richards W. G., Kitajewski J., Deblandre G. A., Kintner C. R., Stark K. L., D114, a novel Notch ligand expressed in arterial endothelium. Genes and Development 2000 14 11 1313 1318 2-s2.0-0034195220 (Pubitemid 30397075)
124. Koch U., Fiorini E., Benedito R., Besseyrias V., Schuster-Gossler K., Pierres M., Manley N. R., Duarte A., MacDonald H. R., Radtke F., Delta-like 4 is the essential, nonredundant ligand for Notchl during thymic T cell lineage commitment. The Journal of Experimental Medicine 2008 205 11 2515 2523 2-s2.0-58149151302 10.1084/jem.20080829
125. Rhen T., Cidlowski J. A., Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. The New England Journal of Medicine 2005 353 16 1711 1658 2-s2.0-26844433194 10.1056/NEJMra050541 (Pubitemid 41464710)
126. Ludvigsson J., Linköping Diabetes Immune Intervention Study Group (LDIISG), The role of immunomodulation therapy in autoimmune diabetes. Journal of Diabetes Science and Technology 2009 3 2 320 330 2-s2.0-77953432137
127. Jackson R., Dolinar R., Srikanta S., Prednisone therapy in early type I diabetes: immunologic effects. Diabetes 1982 31 2 192 2-s2.0-18844472675
128. Riley W. J., Maclaren N. K., Spillar R. S., Reversal of deteriorating glucose tolerance with azathioprine in prediabetics. Transplantation Proceedings 1986 18 4 819 822 2-s2.0-0022493362 (Pubitemid 16054771)
129. Moser M., De Smedt T., Sornasse T., Tielemans F., Chentoufi A. A., Muraille E., Van Mechelen M., Urbain J., Leo O., Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. European Journal of Immunology 1995 25 10 2818 2824 2-s2.0-0028840269 10.1002/eji.1830251016
130. Sherry N. A., Chen W., Kushner J. A., Glandt M., Tang Q., Tsai S., Santamaria P., Bluestone J. A., Brillantes A.-M. B., Herold K. C., Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of β -cells. Endocrinology 2007 148 11 5136 5144 2-s2.0-35548999311 10.1210/en.2007-0358 (Pubitemid 350012634)
131. Wilson J., Cullup H., Lourie R., Sheng Y., Palkova A., Radford K. J.,
132. Lim T. S., Goh J. K., Mortellaro A., Lim C. T., Hämmerling G. J., Ricciardi-Castagnoli P., CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. PLoS ONE 2012 7 9 e45185
133. Toichi E., Torres G., McCormick T. S., Chang T., Mascelli M. A., Kauffman C. L., Aria N., Gottlieb A. B., Everitt D. E., Frederick B., Pendley C. E., Cooper K. D., An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. The Journal of Immunology 2006 177 7 4917 4926 2-s2.0-33749151636 (Pubitemid 44469828)
134. Zhang R., Qian J., Guo J., Yuan Y.-F., Xue K., Suppression of experimental autoimmune uveoretinitis by anti-IL-17 antibody. Current Eye Research 2009 34 4 297 303 2-s2.0-67649662167 10.1080/02713680902741696
135. Röhn T. A., Jennings G. T., Hernandez M., Grest P., Beck M., Zou Y., Kopf M., Bachmann M. F., Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. European Journal of Immunology 2006 36 11 2857 2867 (Pubitemid 44782559)
136. Emamaullee J. A., Davis J., Merani S., Toso C., Elliott J. F., Thiesen A., Shapiro A. M. J., Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009 58 6 1302 1311 2-s2.0-66649113381 10.2337/db08-1113
137. Belghith M., Bluestone J. A., Barriot S., Mégret J., Bach J.-F., Chatenoud L., TGF- β -dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nature Medicine 2003 9 9 1202 1208 2-s2.0-0141796312 10.1038/nm924 (Pubitemid 37173706)
138. Chatenoud L., Bluestone J. A., CD3-specific antibodies: a portal to the treatment of autoimmunity. Nature Reviews Immunology 2007 7 8 622 632 2-s2.0-34547230077 10.1038/nri2134 (Pubitemid 47123550)
139. Coates P. T. H., Krishnan R., Kireta S., Johnston J., Russ G. R., Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice. Gene Therapy 2001 8 16 1224 1233 2-s2.0-0034893459 10.1038/sj.gt.3301513 (Pubitemid 32780810)
140. Machen J., Harnaha J., Lakomy R., Styche A., Trucco M., Giannoukakis N., Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. The Journal of Immunology 2004 173 7 4331 4341 2-s2.0-4644297765 (Pubitemid 39280661)
141. Giannoukakis N., Phillips B., Finegold D., Harnaha J., Trucco M., Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011 34 9 2026 2032 10.2337/dc11-0472
142. Odumosu O., Nicholas D., Yano H., Langridge W., AB toxins: a paradigm switch from deadly to desirable. Toxins 2010 2 7 1612 1645 2-s2.0-79952078677 10.3390/toxins2071612
143. Langridge W., Dénes B., Fodor I., Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases. Current Opinion in Investigational Drugs 2010 11 8 919 928 2-s2.0-77955005217
144. George-Chandy A., Eriksson K., Lebens M., Nordström I., Schön E., Holmgren J., Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infection and Immunity 2001 69 9 5716 5725 2-s2.0-0034873558 10.1128/IAI.69.9.5716-5725.2001 (Pubitemid 32786510)
145. Arakawa T., Chong D. K. X., Langridge W. H. R., Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nature Biotechnology 1998 16 3 292 297 2-s2.0-0031935290 10.1038/nbt0398-292 (Pubitemid 28120111)
146. D'Ambrosio A., Colucci M., Pugliese O., Quintieri F., Boirivant M., Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation. Journal of Leukocyte Biology 2008 84 3 661 668 2-s2.0-50849121427 10.1189/jlb.1207850
147. Isomura I., Yasuda Y., Tsujimura K., Takahashi T., Tochikubo K., Morita A., Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity. Microbiology and Immunology 2005 49 1 79 87 2-s2.0-14644407495 (Pubitemid 40313123)
148. Odumosu O., Payne K., Baez I., Jutzy J., Wall N., Langridge W., Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. Immunobiology 2011 216 4 447 456 2-s2.0-79952193175 10.1016/j.imbio.2010.09.008
149. Odumosu O., Nicholas D., Payne K., Langridge W., Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. Vaccine 2011 29 46 8451 8458 2-s2.0-80053991323 10.1016/j.vaccine. 2011.07.077
150. Najfeld V., Menninger J., Muhleman D., Comings D. E., Gupta S. L., Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12 → p11 by fluorescent in situ hybridization. Cytogenetics and Cell Genetics 1993 64 3-4 231 232 2-s2.0-0027377386 (Pubitemid 23309628)
151. Lee W. S., Lee S. M., Kim M. K., Park S. G., Choi I. W., Choi I., Joo Y. D., Park S. J., Kang S. W., Seo S. K., The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation. International Immunopharmacology 2013 17 3 721 726
152. Harden J. L., Egilmez N. K., Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunological Investigations 2012 41 6-7 738 764 10.3109/08820139.2012.676122
153. Fallarino F., Vacca C., Orabona C., Belladonna M. L., Bianchi R., Marshall B., Keskin D. B., Mellor A. L., Fioretti M. C., Grohmann U., Puccetti P., Functional expression of indoleamine 2,3-dioxygenase by murine CD8 α + dendritic cells. International Immunology 2002 14 1 65 68 2-s2.0-0036155562 (Pubitemid 34083398)
154. Grohmann U., Bianchi R., Orabona C., Fallarino F., Vacca C., Micheletti A., Fioretti M. C., Puccetti P., Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. The Journal of Immunology 2003 171 5 2581 2587 2-s2.0-0042930935 (Pubitemid 37025569)
155. Munn D. H., Sharma M. D., Baban B., Harding H. P., Zhang Y., Ron D., Mellor A. L., GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005 22 5 633 642 2-s2.0-19344377474 10.1016/j.immuni.2005.03.013 (Pubitemid 40719198)
156. Fallarino F., Grohmann U., You S., McGrath B. C., Cavener D. R., Vacca C., Orabona C., Bianchi R., Belladonna M. L., Volpi C., Santamaria P., Fioretti M. C., Puccetti P., The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ -chain and induce a regulatory phenotype in naive T cells. The Journal of Immunology 2006 176 11 6752 6761 2-s2.0-33646893538 (Pubitemid 43787857)
157. Baban B., Chandler P. R., Sharma M. D., Pihkala J., Koni P. A., Munn D. H., Mellor A. L., IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. The Journal of Immunology 2009 183 4 2475 2483 2-s2.0-70149101645 10.4049/jimmunol.0900986
158. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., Ferrara G. B., Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. The Journal of Experimental Medicine 2002 196 4 459 468 2-s2.0-0037136328 10.1084/jem.20020121
159. Koch L. K., Bucher C., Panoskaltsis-Mortari A., Mellor A. L., Munn D. H., Blazar B. R., Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood 2009 114 24 5062 5070 2-s2.0-73949103808 10.1182/blood-2009-06- 227587
160. Mellor A. L., Munn D. H., IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nature Reviews Immunology 2004 4 10 762 774 2-s2.0-5044220930 10.1038/nri1457 (Pubitemid 39336293)
161. Uyttenhove C., Pilotte L., Théate I., Stroobant V., Colau D., Parmentier N., Boon T., Van den Eynde B. J., Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nature Medicine 2003 9 10 1269 1274 2-s2.0-0142137237 10.1038/nm934 (Pubitemid 37279849)
162. Sucher R., Fischler K., Oberhuber R., Kronberger I., Margreiter C., Ollinger R., Schneeberger S., Fuchs D., Werner E. R., Watschinger K., Zelger B., Tellides G., Pilat N., Pratschke J., Margreiter R., Wekerle T., Brandacher G., IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival. The Journal of Immunology 2012 188 1 37 46 2-s2.0-84855370788 10.4049/jimmunol.1002777